vs

Side-by-side financial comparison of GERON CORP (GERN) and NewtekOne, Inc. (NEWT). Click either name above to swap in a different company.

NewtekOne, Inc. is the larger business by last-quarter revenue ($73.3M vs $47.2M, roughly 1.6× GERON CORP). NewtekOne, Inc. runs the higher net margin — 111.8% vs -39.0%, a 150.8% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -2.7%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 12.2%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

NewTek, Inc., is a hardware and software company, based in San Antonio, Texas, that produced live and post-production video tools and visual imaging software for personal computers. The company was founded in 1985 in Topeka, Kansas, United States, by Tim Jenison and Paul Montgomery. On April 1, 2019, it was announced that NewTek would be acquired by Vizrt.

GERN vs NEWT — Head-to-Head

Bigger by revenue
NEWT
NEWT
1.6× larger
NEWT
$73.3M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+69.7% gap
GERN
67.1%
-2.7%
NEWT
Higher net margin
NEWT
NEWT
150.8% more per $
NEWT
111.8%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
12.2%
NEWT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
NEWT
NEWT
Revenue
$47.2M
$73.3M
Net Profit
$-18.4M
$19.5M
Gross Margin
Operating Margin
-29.4%
Net Margin
-39.0%
111.8%
Revenue YoY
67.1%
-2.7%
Net Profit YoY
30.3%
6.6%
EPS (diluted)
$-0.03
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
NEWT
NEWT
Q4 25
$73.3M
Q3 25
$47.2M
$74.9M
Q2 25
$49.0M
$70.2M
Q1 25
$39.6M
$66.3M
Q4 24
$75.4M
Q3 24
$28.3M
$62.8M
Q2 24
$882.0K
$61.1M
Q1 24
$304.0K
$58.3M
Net Profit
GERN
GERN
NEWT
NEWT
Q4 25
$19.5M
Q3 25
$-18.4M
$17.9M
Q2 25
$-16.4M
$13.7M
Q1 25
$-19.8M
$9.4M
Q4 24
$18.3M
Q3 24
$-26.4M
$11.9M
Q2 24
$-67.4M
$10.9M
Q1 24
$-55.4M
$9.7M
Operating Margin
GERN
GERN
NEWT
NEWT
Q4 25
Q3 25
-29.4%
Q2 25
-25.4%
Q1 25
-42.2%
Q4 24
Q3 24
-99.8%
Q2 24
-7860.9%
Q1 24
-18465.1%
Net Margin
GERN
GERN
NEWT
NEWT
Q4 25
111.8%
Q3 25
-39.0%
23.9%
Q2 25
-33.4%
19.5%
Q1 25
-50.1%
14.1%
Q4 24
24.3%
Q3 24
-93.5%
19.0%
Q2 24
-7639.8%
17.9%
Q1 24
-18220.4%
16.6%
EPS (diluted)
GERN
GERN
NEWT
NEWT
Q4 25
$0.64
Q3 25
$-0.03
$0.67
Q2 25
$-0.02
$0.52
Q1 25
$-0.03
$0.35
Q4 24
$0.70
Q3 24
$-0.04
$0.45
Q2 24
$-0.10
$0.43
Q1 24
$-0.09
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
NEWT
NEWT
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
$819.9M
Stockholders' EquityBook value
$248.7M
$397.6M
Total Assets
$567.4M
$2.7B
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
NEWT
NEWT
Q4 25
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$189.8M
Total Debt
GERN
GERN
NEWT
NEWT
Q4 25
$819.9M
Q3 25
$748.5M
Q2 25
$657.3M
Q1 25
$774.0M
Q4 24
$708.0M
Q3 24
$655.8M
Q2 24
$652.0M
Q1 24
$662.5M
Stockholders' Equity
GERN
GERN
NEWT
NEWT
Q4 25
$397.6M
Q3 25
$248.7M
$386.7M
Q2 25
$259.5M
$312.2M
Q1 25
$268.2M
$302.3M
Q4 24
$296.3M
Q3 24
$292.3M
$281.8M
Q2 24
$306.7M
$274.0M
Q1 24
$344.9M
$254.1M
Total Assets
GERN
GERN
NEWT
NEWT
Q4 25
$2.7B
Q3 25
$567.4M
$2.4B
Q2 25
$555.2M
$2.1B
Q1 25
$562.5M
$2.1B
Q4 24
$2.1B
Q3 24
$444.9M
$1.7B
Q2 24
$449.4M
$1.6B
Q1 24
$482.1M
$1.5B
Debt / Equity
GERN
GERN
NEWT
NEWT
Q4 25
2.06×
Q3 25
1.94×
Q2 25
2.11×
Q1 25
2.56×
Q4 24
2.39×
Q3 24
2.33×
Q2 24
2.38×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
NEWT
NEWT
Operating Cash FlowLast quarter
$-13.6M
$-579.2M
Free Cash FlowOCF − Capex
$-579.3M
FCF MarginFCF / Revenue
-790.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-29.64×
TTM Free Cash FlowTrailing 4 quarters
$-1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
NEWT
NEWT
Q4 25
$-579.2M
Q3 25
$-13.6M
$-167.3M
Q2 25
$-27.4M
$-199.8M
Q1 25
$-48.0M
$-60.7M
Q4 24
$-153.0M
Q3 24
$-58.9M
$-25.7M
Q2 24
$-53.5M
$2.9M
Q1 24
$-62.3M
$-38.7M
Free Cash Flow
GERN
GERN
NEWT
NEWT
Q4 25
$-579.3M
Q3 25
$-167.3M
Q2 25
$-199.9M
Q1 25
$-60.7M
Q4 24
$-153.5M
Q3 24
$-25.9M
Q2 24
$-53.7M
$2.9M
Q1 24
$-62.9M
$-38.7M
FCF Margin
GERN
GERN
NEWT
NEWT
Q4 25
-790.0%
Q3 25
-223.3%
Q2 25
-284.7%
Q1 25
-91.6%
Q4 24
-203.6%
Q3 24
-41.2%
Q2 24
-6086.6%
4.7%
Q1 24
-20680.3%
-66.5%
Capex Intensity
GERN
GERN
NEWT
NEWT
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.6%
Q3 24
0.0%
0.4%
Q2 24
23.4%
0.1%
Q1 24
202.3%
0.1%
Cash Conversion
GERN
GERN
NEWT
NEWT
Q4 25
-29.64×
Q3 25
-9.35×
Q2 25
-14.58×
Q1 25
-6.48×
Q4 24
-8.35×
Q3 24
-2.15×
Q2 24
0.27×
Q1 24
-4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons